ClearPoint Neuro (CLPT) Non-Current Deferred Tax Liability (2013 - 2026)

ClearPoint Neuro (CLPT) posted Non-Current Deferred Tax Liability of $354000.0 for Q1 2026, little changed sequentially from $354000.0 in Q4 2025.

ClearPoint Neuro (CLPT) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends

ClearPoint Neuro has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $354000.0 in Q1 2026.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $354000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $354000.0 (changed N/A YoY) and the FY2025 annual result came in at $354000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability was little changed at $354000.0 in Q1 2026 per CLPT's latest filing, from $354000.0 in the prior quarter.
Over five years, Non-Current Deferred Tax Liability peaked at $354000.0 in Q4 2025 and troughed at $354000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.95 Bn	193.35 Bn	7.27 Bn
2	Stryker	128.10 Bn	124.63 Bn	4.50 Bn
3	Medtronic	118.91 Bn	109.69 Bn	6.41 Bn
4	Boston Scientific	73.43 Bn	72.89 Bn	3.85 Bn
5	Edwards Lifesciences	51.91 Bn	47.66 Bn	1.35 Bn
6	Dexcom	34.52 Bn	32.58 Bn	830.00 Mn
7	GE HealthCare Technologies	33.94 Bn	31.83 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.14 Bn	22.66 Bn	684.20 Mn
10	ClearPoint Neuro	467.73 Mn	438.33 Mn	6.71 Mn

Download Data